newsfilter
← Latest News
FDA Approved Drugs·

Approval of Repatha, Bla #125522

Approval Date: 10/09/2026; Drug Name: Repatha, Bla #125522; Active Ingredients: EVOLOCUMAB; Company: Amgen Inc; Submission Status: Approval; Application Number: 125522

Company
AMGEN INC
Keywords
AMGEN INC